Technical Analysis for AYTU - Aytu BioScience, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Stochastic Sell Signal | Bearish | -7.83% | |
| Upper Bollinger Band Walk | Strength | -7.83% | |
| Gapped Up | Strength | -7.83% |
| Alert | Time |
|---|---|
| Down 2 % | about 14 hours ago |
| Possible Pocket Pivot | about 14 hours ago |
| Possible Inside Day | about 15 hours ago |
| 60 Minute Opening Range Breakout | about 15 hours ago |
| Up 2% | about 15 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/15/2024
Aytu BioScience, Inc. Description
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alcohol Prostate Cancer Urology In Vitro Hormones Fertility Ketones Estrogen Imaging Agent Infertility Testosterone Urinary Tract Infection In Vitro Diagnostic Device Androstanes Company's Pipeline Male Infertility Urinary Tract Infections
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.5 |
| 52 Week Low | 1.38 |
| Average Volume | 18,202 |
| 200-Day Moving Average | 2.61 |
| 50-Day Moving Average | 3.01 |
| 20-Day Moving Average | 2.98 |
| 10-Day Moving Average | 3.15 |
| Average True Range | 0.16 |
| RSI (14) | 50.74 |
| ADX | 20.63 |
| +DI | 25.84 |
| -DI | 18.34 |
| Chandelier Exit (Long, 3 ATRs) | 2.97 |
| Chandelier Exit (Short, 3 ATRs) | 3.11 |
| Upper Bollinger Bands | 3.36 |
| Lower Bollinger Band | 2.60 |
| Percent B (%b) | 0.6 |
| BandWidth | 25.44 |
| MACD Line | 0.07 |
| MACD Signal Line | 0.04 |
| MACD Histogram | 0.0333 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.57 | ||||
| Resistance 3 (R3) | 3.63 | 3.51 | 3.49 | ||
| Resistance 2 (R2) | 3.51 | 3.38 | 3.49 | 3.46 | |
| Resistance 1 (R1) | 3.29 | 3.30 | 3.23 | 3.23 | 3.43 |
| Pivot Point | 3.17 | 3.17 | 3.15 | 3.15 | 3.17 |
| Support 1 (S1) | 2.95 | 3.04 | 2.89 | 2.89 | 2.69 |
| Support 2 (S2) | 2.83 | 2.96 | 2.81 | 2.66 | |
| Support 3 (S3) | 2.61 | 2.83 | 2.64 | ||
| Support 4 (S4) | 2.55 |
